nach oben

Die Urologie

Erschienen in:

01.12.2012 | Leitthema

Aspekte der traditionellen indischen Medizin (Ayurveda) in der Urologie

verfasst von: Dr. J. Mani, S. Kumar, G.J. Dobos, A. Haferkamp

Erschienen in: Die Urologie | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Ayurveda ist global gesehen das älteste System und die zumeist angewandte Naturheilkunde in Indien. Der Unterschied zur westlichen Medizin besteht darin, dass diese Heilkunde auf jahrtausendealte Erfahrungswerte, Empirie und Intuition basiert. Diese wurden über Generationen sowohl mündlich als auch über Aufzeichnungen übermittelt. Ayurveda bezieht sich nicht nur auf den Körper, sondern auch auf den Geist. Demnach resultieren die meisten Krankheiten durch die psychophysiologischen und pathologischen Veränderungen im Körper. Letztendlich ist die ausgeglichene Balance zwischen Körper, Geist und Seele die ayurvedische Definition von Gesundheit. Ayurvedische Medizin wird im Rahmen der Behandlung der Urolithiasis zur Diurese, zur Litholyse, spasmoanalgetisch und antimikrobiell eingesetzt.

Sharma A, Chandraker S, Patel VK, Ramteke P (2009) Antibacterial activity of medicinal plants against pathogens causing complicated urinary tract infections. Indian J Pharm Sci 71:136–139PubMedCrossRef

Pereira RS, Sumita TC, Furlan MR et al (2004) Antibacterial activity of essential oils on microorganisms isolated from urinary tract infection. Rev Saude Publica 38:326–328PubMedCrossRef

Bag A, Bhattacharyya SK, Chattopadhyay RR (2008) Medicinal plants and urinary tract infections: an update. Pharmacog Rev 4:277–284

Barros ME, Schor N, Boim MA (2003) Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol Res 30(6):374–379PubMed

Barros ME, Lima R, Mercuri LP et al (2006) Effect of extract of Phyllanthus niruri on crystal deposition in experimental urolithiasis. Urol Res 34(6):351–357PubMedCrossRef

Micali S, Sighinolfi MC, Celia A et al (2006) Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol 176(3):1020–1022PubMedCrossRef

Sangeeta D, Sidhu H, Thind SK, Nath R (1994) Effect of Tribulus terrestris on oxalate metabolism in rats. J Ethnopharmacol 44(2):61–66PubMedCrossRef

10.

Christina AJ, Packia Lakshmi M, Nagarajan M, Kurian S (2002) Modulatory effect of Cyclea peltata Lam. on stone formation induced by ethylene glycol treatment in rats. Methods Find Exp Clin Pharmacol 24(2):77–79PubMedCrossRef

11.

Christina AJ, Priya Mole M, Moorthy P (2002) Studies on the antilithic effect of Rotula aquatica lour in male Wistar rats. Methods Find Exp Clin Pharmacol 24(6):357–359PubMedCrossRef

12.

Vasava YR, Bhuyan C, Rajagopala M et al (2010) Effect of Mahayavanala Roma Kshara and Dhanyaka Gokshura Ghrita in benign prostatic hyperplasia. Ayu 31(3):332–337PubMedCrossRef

13.

Sengupta G, Hazra A, Kundu A, Ghosh A (2011) Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged > 50 years: a double-blind, double-dummy, randomized controlled trial. Clin Ther 33(12):1943–1952PubMedCrossRef

14.

Reddy S, Aggarwal BB (1994) Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 341:19–22PubMedCrossRef

15.

Singh S, Aggarwal BB (1995) Activation of transcription factor NF kappa B is suppressed by curcumin (diferuloylmethane) (corrected). J Biol Chem 270:24995–25000PubMedCrossRef

16.

Natarajan K, Singh S, Burke TR Jr et al (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 93:9090–9095PubMedCrossRef

17.

Singh S, Natarajan K, Aggarwal BB (1996) Capsaicin (8-methyl-Nvanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol 157:4412–4420PubMed

18.

Chaturvedi MM, Kumar A, Darnay BG et al (1997) Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappa B activation, Ikappa B alpha phosphorylation, and degradation. J Biol Chem 272:30129–30134PubMedCrossRef

19.

Kumar A, Dhawan S, Aggarwal BB (1998) Emodin (3-methyl-1,6,8- trihydroxyanthraquinone) inhibits TNF-induced NF-kappa B activation, Ikappa B degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17:913–918PubMedCrossRef

20.

Kumar A, Dhawan S, Hardegen NJ et al (1998) Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappa B activation. Biochem Pharmacol 55:775–783PubMedCrossRef

21.

Manna SK, Mukhopadhyay A, Van NT et al (1999) Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun Nterminal kinase, and apoptosis. J Immunol 163:6800–6809PubMed

22.

Manna SK, Gad YP, Mukhopadhyay A et al (1999) Suppression of tumor necrosis factor-activated nuclear transcription factor kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone. Biochem Pharmacol 57:763–774PubMedCrossRef

23.

Chainy GB, Manna SK, Chaturvedi MM et al (2000) Anethole blocksboth early and late cellular responses transduced by tumornecrosis factor: effect on NF-kappa B, AP-1, JNK, MAPKK and apoptosis. Oncogene 19:2943–2950PubMedCrossRef

24.

Manna SK, Sah NK, Newman RA et al (2000) Oleandrin suppressesactivation of nuclear transcription factor-kappa B, activatorprotein-1, and c-Jun NH2-terminal kinase. Cancer Res 60:3838–3847PubMed

25.

Manna SK, Mukhopadhyay A, Aggarwal BB (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164:6509–6519PubMed

26.

Mukhopadhyay A, Bueso-Ramos C, Chatterjee D et al (2001) Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20:7597–7609PubMedCrossRef

27.

Anto RJ, Mukhopadhyay A, Denning K et al (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23:143–150PubMedCrossRef

28.

Ashikawa K, Majumdar S, Banerjee S et al (2002) Piceatannol inhibits TNF-induced NF-kappa B activation and NF-kappa B-mediated gene expression through suppression of kappa B alpha kinase and p65 phosphorylation. J Immunol 169:6490–6497PubMed

29.

Banerjee S, Bueso-Ramos C, Aggarwal BB (2002) Suppression of 7,12-imethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappa B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62:4945–4954PubMed

30.

Mukhopadhyay A, Banerjee S, Stafford LJ et al (2002) Curcumininduced suppression of cell proliferation correlates with downregulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21:8852–8861PubMedCrossRef

31.

Bharti AC, Donato N, Aggarwal BB (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171:3863–3871PubMed

32.

Bharti AC, Donato N, Singh S et al (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa B alpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101:1053–1062, 43PubMedCrossRef

33.

Estrov Z, Shishodia S, Faderl S et al (2003) Resveratrol blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-kappa B, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102:987–995PubMedCrossRef

34.

Manna SK, Bueso-Ramos C, Alvarado F et al (2003) Calagualine inhibits nuclear transcription factors-kappa B activated by various inflammatory and tumor promoting agents. Cancer Lett 190:171–182PubMedCrossRef

35.

Shishodia S, Majumdar S, Banerjee S et al (2003) Ursolic acid inhibits nuclear factor-kappa B activation induced by carcinogenic agents through suppression of Ikappa B alpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63:4375–4383PubMed

36.

Shishodia S, Potdar P, Gairola CG et al (2003) Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappa B activation through inhibition of Ikappa B alpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24:1269–1279PubMedCrossRef

37.

Takada Y, Aggarwal BB (2003) Betulinic acid suppresses carcinogeninduced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase- 2 and matrix metalloprotease-9. J Immunol 171:3278–3286PubMed

38.

Aggarwal S, Takada Y, Singh S et al (2004) Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappa B signaling. Int J Cancer 111:679–692PubMedCrossRef

39.

Bharti AC, Takada Y, Aggarwal BB (2004) Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligandinduced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172:5940–5947PubMed

40.

Li L, Aggarwal BB, Shishodia S et al (2004) Nuclear factor-kappa B and Ikappa B kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101:2351–2362PubMedCrossRef

41.

Shishodia S, Aggarwal BB (2004) Guggulsterone inhibits NF-kappa B and Ikappa B alpha kinase activation, suppresses expression of antiapoptotic gene products, and enhances apoptosis. J Biol Chem 279:47148–47158PubMedCrossRef

42.

Takada Y, Aggarwal BB (2004) Flavopiridol inhibits NF-kappa B activation induced by various carcinogens and inflammatory agents through inhibition of Ikappa B alpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J Biol Chem 279:4750–4759PubMedCrossRef

43.

Aggarwal BB, Shishodia S, Takada Y et al (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-kappa B pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11:7490–7498PubMedCrossRef

44.

Ichikawa H, Takada Y, Murakami A et al (2005) Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J Immunol 174:7383–7392PubMed

45.

Shishodia S, Amin HM, Lai R et al (2005) Curcumin (diferuloylmethane) inhibits constitutive NF-kappa B activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70:700–713PubMedCrossRef

46.

Siwak DR, Shishodia S, Aggarwal BB et al (2005) Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of Ikappa B kinase and nuclear factor kappa B activity and are independent of the B-Raf/mitogenactivated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104:879–890PubMedCrossRef

47.

Takada Y, Murakami A, Aggarwal BB (2005) Zerumbone abolishes NF kappa B and Ikappa B alpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 24:6957–6969PubMedCrossRef

48.

Takada Y, Andreeff M, Aggarwal BB (2005) Indole-3-carbinol suppresses NF-kappa B and Ikappa B alpha kinase activation, causing inhibition of expression of NF-kappa B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106:641–649PubMedCrossRef

49.

Takada Y, Kobayashi Y, Aggarwal BB (2005) Evodiamine abolishes constitutive and inducible NF-kappa B activation by inhibiting Ikappa B alpha kinase activation, thereby suppressing NF-kappa B regulated antiapoptotic and metastatic gene expression, upregulating apoptosis, and inhibiting invasion. J Biol Chem 280:17203–17212PubMedCrossRef

50.

Adams LS, Seeram NP, Aggarwal BB et al (2006) Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54:980–985PubMedCrossRef

51.

Aggarwal S, Ichikawa H, Takada Y et al (2006) Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of Ikappa B alpha kinase and Akt activation. Mol Pharmacol 69:195–206PubMed

52.

Chakravarti N, Myers JN, Aggarwal BB (2006) Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 119(6):1268–1275PubMedCrossRef

53.

Ichikawa H, Takada Y, Shishodia S et al (2006) Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappa B (NF-kappa B) activation and NF-kappa B-regulated gene expression. Mol Cancer Ther 5:1434–1445PubMedCrossRef

54.

Ichikawa H, Murakami A, Aggarwal BB (2006) 19-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappa B activation. Mol Cancer Res 4:275–281PubMedCrossRef

55.

Ichikawa H, Aggarwal BB (2006) Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand and by tumor cells by suppressing nuclear factor-kappa B activation. Clin Cancer Res 12:662–668PubMedCrossRef

56.

Sandur SK, Ichikawa H, Sethi G et al (2006) Plumbagin (5-hydroxy-2- methyl-1,4-naphthoquinone) suppresses NF-kappa B activation and NF-kappa B-regulated gene products through modulation of p65 and Ikappa B alpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 281:17023–17033PubMedCrossRef

57.

Sethi G, Ahn KS, Sandur SK et al (2006) Indirubin enhances TNFinduced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J Biol Chem

58.

Shishodia S, Aggarwal BB (2006) Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene 25:1463–1473PubMedCrossRef

59.

Takada Y, Ichikawa H, Badmaev V et al (2006) Acetyl-11-keto-betaboswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol 176:3127–3140PubMed

60.

Zambre AP, Kulkarni VM, Padhye S et al (2006) Novel curcumin analogs targeting TNF-induced NF-kappa B activation and proliferation in human leukemic KBM-5 cells. Bioorg Med Chem

61.

Fukuda K, Hibiya Y, Mutoh M et al (1999) Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66:227–233PubMedCrossRef

62.

Hong CH, Hur SK, Oh OJ et al (2002) Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J Ethnopharmacol 83:153–159PubMedCrossRef

63.

Kiemer AK, Hartung T, Huber C et al (2003) Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappa B pathway. J Hepatol 38:289–297PubMedCrossRef

64.

Li RW, Leach DN, Myers SP et al (2004) Anti-inflammatory activity, cytotoxicity and active compounds of Tinospora smilacina Benth. Phytother Res 18:78–83PubMedCrossRef

65.

Chun KS, Keum YS, Han SS et al (2003) Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappa B activation. Carcinogenesis 24:1515–1524PubMedCrossRef

66.

Androulakis XM, Muga SJ, Chen F et al (2006) Chemopreventive effects of Khaya senegalensis bark extract on human colorectal cancer. Anticancer Res 26:2397–2405PubMed

67.

Huss U, Ringbom T, Perera P et al (2002) Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. J Nat Prod 65:1517–1521PubMedCrossRef

68.

Marsik P, Kokoska L, Landa P et al (2005) In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med 71:739–742PubMedCrossRef

69.

Lev-Ari S, Maimon Y, Strier L et al (2006) Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines. J Soc Integr Oncol 4:21–26PubMed

70.

Park C, Kim GY, Kim GD et al (2006) Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15:1225–1231PubMed

71.

Sharma MK, Kumar M, Kumar A (2002) Ocimum sanctum aqueous leaf extract provides protection against mercury induced toxicity in Swiss albino mice. Indian J Exp Biol 40:1079–1082PubMed

72.

Samudralwar DL, Garg AN (1996) Minor and trace elemental determination in the Indian herbal and other medicinal preparations. Biol Trace Elem Res 54:113–121PubMedCrossRef

73.

Rekha PS, Kuttan G, Kuttan R (2001) Antioxidant activity of Brahma rasayana. Indian J Exp Biol 39:447–452PubMed

74.

Paranjpe P, Patki P, Patwardhan B (1990) Ayurvedic treatment of obesity: a randomised double-blind, placebo-controlled clinical trial. J Ethnopharmacol 29:1–11PubMedCrossRef

75.

Aggarwal BB, Bhatt ID, Ichikawa H et al (2007) Curcumin—biological and medicinal properties. In: Ravindran PN, Babu KN, Sivaraman K (Hrsg) Turmeric the Genus Curcuma. CRC Press, NY, S 297–368

76.

Shenouda NS, Zhou C, Browning JD et al (2004) Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutr Cancer 49:200–208PubMedCrossRef

77.

Shankar S, Chen Q, Sarva K et al (2007) Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. J Mol Signal 2:10PubMedCrossRef

78.

Goel A, Kunnumakkara AB, Aggarwal BB (2007) Curcumin as Curecumin: from kitchen to clinic. Biochem Pharmacol

79.

Pang X, Yi Z, Zhang X et al (2009) Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 69(14):5893–5900PubMedCrossRef

80.

Singh SV, Choi S, Zeng Y et al (2007) Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res 67(15):7439–7449PubMedCrossRef

81.

Singh SV, Zeng Y, Xiao D et al (2005) Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak. Mol Cancer Ther 4(11):1747–1754PubMedCrossRef

82.

Xiao D, Singh SV (2008) z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo. Mol Cancer Ther 7(1):171–180PubMedCrossRef

83.

Ru P, Steele R, Nerurkar PV et al (2011) Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prev Res (Phila) 4(12):2122–2130CrossRef

84.

Tong QS, Zheng LD, Lu P et al (2006) Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells. Anticancer Drugs 17(3):279–287PubMedCrossRef

85.

Watanabe FT, Chade DC, Reis ST et al (2011) Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model. Clinics (Sao Paulo) 66(12):2121–2124

86.

Chadalapaka G, Jutooru I, Burghardt R, Safe S (2010) Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Mol Cancer Res 8(5):739–750PubMedCrossRef

87.

Goel A, Aggarwal BB (2010) Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radiprotector for normal organs. Nutr Cancer 62(7):919–930 (Review)PubMedCrossRef

88.

Chen X, Hasuma T, Yano Y et al (1997) Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res 17:2555–2564PubMed

89.

Woo JH, Kim YH, Choi YJ et al (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24(7):1199–1208PubMedCrossRef

90.

Frank N, Knauft J, Amelung F et al (2003) No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat Res 523–524:127–135

91.

Garodia P, Ichikawa H, Malani N et al (2007) From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol Winter 5(1):25–37CrossRef

92.

Anand P, Sundaram C, Jhurani S et al (2008) Curcumin and cancer: an „old-age“ disease with an „age-old“ solution. Cancer Lett 267(1):133–164PubMedCrossRef

Titel: Aspekte der traditionellen indischen Medizin (Ayurveda) in der Urologie
verfasst von: Dr. J. Mani
S. Kumar
G.J. Dobos
A. Haferkamp
Publikationsdatum: 01.12.2012
Verlag: Springer-Verlag
Erschienen in: Die Urologie / Ausgabe 12/2012
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI: https://doi.org/10.1007/s00120-012-3063-7

Neu im Fachgebiet Urologie

22.04.2024 | Prostatakarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Aspekte der traditionellen indischen Medizin (Ayurveda) in der Urologie

Zusammenfassung

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2012

Erratum zu: Metastasenresektion beim Prostatakarzinom

Magnetresonanzurographie in der Kinderurologie

Neue Behandlungskonzepte von Symptomen des unteren Harntraktes beim Mann

URO-Telegramm

Unkonventionelle Behandlungsmethoden in der Urologie

Schon im 19. Jahrhundert war die Beschneidung Gegenstand der Diskussion

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie